Virtus ETF Advisers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$265K Sell
1,012
-44
-4% -$11.3K 0.1% 248
2026
Q2
$266K Sell
1,056
-44
-4% -$9.47K 0.1% 228
2026
Q1
$239K Sell
1,100
-264
-19% -$58.6K 0.11% 207
2025
Q4
$312K Buy
1,364
+423
+45% +$96.4K 0.15% 164
2025
Q3
$218K Buy
941
+897
+2,039% +$183K 0.12% 204
2025
Q2
$8.17K Hold
44
– – 0.01% 423
2025
Q1
$9.22K Buy
+44
New +$8.55K 0.01% 391
2023
Q3
– Sell
-4,785
Closed -$645K – 436
2023
Q2
$645K Sell
4,785
-1,189
-20% -$174K 0.38% 121
2023
Q1
$952K Buy
5,974
+721
+14% +$110K 0.52% 34
2022
Q4
$849K Buy
5,253
+655
+14% +$100K 0.44% 48
2022
Q3
$617K Sell
4,598
-146
-3% -$21K 0.25% 163
2022
Q2
$727K Buy
+4,744
New +$725K 0.27% 107
2020
Q2
– Sell
-167
Closed -$13K – 443
2020
Q1
$13K Sell
167
-211
-56% -$18K 0.01% 364
2019
Q4
$33K Buy
+378
New +$31.4K 0.01% 312

Other funds holding ABBV

Virtus ETF Advisers's ABBV Position: Q3 2026 in Review

Virtus ETF Advisers reduced its AbbVie (ABBV) stake by 4.2% in Q3 2026, selling an estimated $11.3K and leaving 1,012 shares worth $265K. The position accounts for 0.1% of the portfolio, ranked #248.

Virtus ETF Advisers first reported a position in ABBV in Q4 2019 and has held it in 14 quarters since. The position peaked at $952K in Q1 2023. 4,255 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Virtus ETF Advisers held 1,012 shares of AbbVie worth $265K as of Q3 2026.
  • Virtus ETF Advisers sold 44 AbbVie shares in Q3 2026, an estimated $11.3K.
  • AbbVie made up 0.1% of Virtus ETF Advisers's portfolio in Q3 2026, its #248 holding.
  • Virtus ETF Advisers first reported a position in AbbVie in Q4 2019 and has held it in 14 quarters since.
  • Virtus ETF Advisers's AbbVie position peaked at $952K in Q1 2023.
  • 4,255 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.